WebinarsNew
Deep DiveNew
Explore Business Standard
Specialty chemicals manufacturer Epigral is targeting revenue of Rs 5,000 crore by 2030-31, driven by upcoming production scale-ups in CPVC Resin and Epichlorohydrin (ECH), a senior company executive said. The company expects to reach Rs 2,900 crore in revenue this fiscal year following revenue of Rs 2,5002,530 crore in 2026. "In FY26, we ended with around Rs 2,500-2,530 crore of revenue, and at the current pace of growth, we expect around Rs 2,900 crore this financial year. "The capacity increase in production of CPVC Resin and ECH will start adding to the revenue from next year. Therefore, we are expecting to double our revenue to around Rs 5,000 crore by 2030-31," Epigral Chairman and Managing Director Maulik Patel told PTI. The company's CPVC Resin capacity is being doubled from 75,000 TPA to 1,50,000 TPA, while ECH capacity is being doubled from 50,000 TPA to 1,00,000 TPA at the company's existing units in Dahej, Gujarat. "Both capacity expansions are expected to be commissio
Specialty chemicals maker Vipul Organics Ltd on Monday said its unit, AdiMem Technologies, has commenced commercial sales of indigenously developed membranes, as it aims to capture a meaningful share of India's filtration market. AdiMem, which showcased its technology at IFAT India 2025 earlier this year, will launch Reverse Osmosis (RO) and Ultrafiltration (UF) membrane manufacturing at its Sayakha, Gujarat facility using proprietary Reverse Phase Transition technology, the company said in a regulatory filing. Vipul Organics said it was targeting membranes and membrane-based solutions to account for 25 per cent of its topline within three years. India's filtration market is projected to reach USD 6.33 billion by 2033. AdiMem supplies membranes alongside end-to-end effluent and sewage treatment plants and pre-treatment systems, serving the chemicals, pharmaceutical and other industrial sectors. Its product lineup spans microfiltration, ultrafiltration, nanofiltration and reverse ..